1 |
|
2 |
|
3 |
|
4 |
Qin LZ, Li W, Huang Y, et al. PTX3 expression in the plasma of elderly ACI patients and its relationship with severity and prognosis of the disease[J]. Eur Rev Med Pharmacol Sci, 2016, 20(19):4112-4118.
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
许位, 张园园, 高敬华, 等. 急性脑梗死患者血清sdLDL-C与PTX-3水平与颈动脉粥样硬化斑块性质的关系[J]. 中风与神经疾病杂志, 2019, 36(8):704-707.
|
10 |
|
11 |
|
12 |
Rajkovic I, Wong R, Lemarchand E, et al. Pentraxin 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke[J]. J Mol Med (Berl), 2018, 96(12):1319-1332. DOI: 10.1007/s00109-018-1698-6.
|
13 |
许位, 张园园, 高敬华, 等. 急性脑梗死患者血清sdLDL-C与PTX-3水平与颈动脉粥样硬化斑块性质的关系[J]. 中风与神经疾病杂志, 2019, 36(8):704-707.
|
14 |
Carrizzo A, Procaccini C, Lenzi P, et al. PTX3: an inflammatory protein modulating ultrastructure and bioenergetics of human endothelial cells[J]. Immun Ageing, 2019, 16:4. DOI: 10.1186/s12979-019-0144-0.
|
15 |
|